CVS Health EBITDA 2010-2025 | CVS

CVS Health annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • CVS Health EBITDA for the quarter ending March 31, 2025 was $4.528B, a 32.82% increase year-over-year.
  • CVS Health EBITDA for the twelve months ending March 31, 2025 was $14.232B, a 16.63% decline year-over-year.
  • CVS Health 2024 annual EBITDA was $13.113B, a 27.59% decline from 2023.
  • CVS Health 2023 annual EBITDA was $18.109B, a 48.7% increase from 2022.
  • CVS Health 2022 annual EBITDA was $12.178B, a 33.19% decline from 2021.
CVS Health Annual EBITDA
(Millions of US $)
2024 $13,113
2023 $18,109
2022 $12,178
2021 $18,227
2020 $18,352
2019 $16,358
2018 $12,888
2017 $12,198
2016 $12,861
2015 $11,567
2014 $10,730
2013 $9,907
2012 $8,963
2011 $7,899
2010 $7,606
2009 $7,814
CVS Health Quarterly EBITDA
(Millions of US $)
2025-03-31 $4,528
2024-12-31 $3,515
2024-09-30 $1,993
2024-06-30 $4,196
2024-03-31 $3,409
2023-12-31 $4,507
2023-09-30 $4,817
2023-06-30 $4,338
2023-03-31 $4,447
2022-12-31 $4,702
2022-09-30 $-2,869
2022-06-30 $5,751
2022-03-31 $4,594
2021-12-31 $3,435
2021-09-30 $4,626
2021-06-30 $5,463
2021-03-31 $4,703
2020-12-31 $3,663
2020-09-30 $4,363
2020-06-30 $5,782
2020-03-31 $4,544
2019-12-31 $4,133
2019-09-30 $4,020
2019-06-30 $4,404
2019-03-31 $3,801
2018-12-31 $3,859
2018-09-30 $3,194
2018-06-30 $3,195
2018-03-31 $2,640
2017-12-31 $3,797
2017-09-30 $3,114
2017-06-30 $2,875
2017-03-31 $2,412
2016-12-31 $3,648
2016-09-30 $3,435
2016-06-30 $2,976
2016-03-31 $2,802
2015-12-31 $3,332
2015-09-30 $2,863
2015-06-30 $2,750
2015-03-31 $2,622
2014-12-31 $2,810
2014-09-30 $2,723
2014-06-30 $2,696
2014-03-31 $2,501
2013-12-31 $2,675
2013-09-30 $2,615
2013-06-30 $2,421
2013-03-31 $2,196
2012-12-31 $2,740
2012-09-30 $2,257
2012-06-30 $2,139
2012-03-31 $1,827
2011-12-31 $2,354
2011-09-30 $1,991
2011-06-30 $1,875
2011-03-31 $1,679
2010-12-31 $2,121
2010-09-30 $1,848
2010-06-30 $1,869
2010-03-31 $1,768
2009-12-31 $2,234
2009-09-30 $1,867
2009-06-30 $1,982
2009-03-31 $1,731
Sector Industry Market Cap Revenue
Medical Medical Services $83.011B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.077B 27.58
Elevance Health (ELV) United States $78.142B 10.08
Cencora (COR) United States $57.628B 20.05
DiDi Global (DIDIY) China $23.768B 25.25
Natera (NTRA) United States $22.306B 0.00
Labcorp Holdings (LH) United States $21.229B 17.22
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.751B 0.00
Solventum (SOLV) United States $13.128B 13.90
CochLear (CHEOY) Australia $12.788B 0.00
ICON (ICLR) Ireland $12.281B 11.42
Revvity (RVTY) United States $12.070B 20.77
Viatris (VTRS) United States $10.857B 3.73
Medpace Holdings (MEDP) United States $9.434B 25.06
Avantor (AVTR) United States $9.336B 13.56
Sonic Healthcare (SKHHY) Australia $8.582B 0.00
HealthEquity (HQY) United States $8.405B 36.81
Charles River Laboratories (CRL) United States $8.038B 15.75
Caris Life Sciences,�Inc (CAI) United States $6.772B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.024B 29.58
BrightSpring Health Services (BTSG) United States $3.667B 33.65
Sotera Health (SHC) United States $3.375B 19.18
Surgery Partners (SGRY) United States $2.855B 37.12
Alignment Healthcare (ALHC) United States $2.647B 0.00
Concentras Parent (CON) United States $2.621B 15.15
Organon (OGN) United States $2.605B 2.77
GeneDx Holdings (WGS) United States $2.480B 95.51
Ardent Health (ARDT) United States $2.041B 8.70
Progyny (PGNY) United States $2.024B 44.55
PACS (PACS) United States $1.949B 0.00
Premier (PINC) United States $1.767B 13.41
GoodRx Holdings (GDRX) United States $1.750B 35.00
Teladoc Health (TDOC) United States $1.546B 0.00
Establishment Labs Holdings (ESTA) $1.329B 0.00
Pediatrix Medical (MD) United States $1.160B 8.82
CareDx (CDNA) United States $1.149B 17.94
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.956B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
Nutex Health (NUTX) United States $0.653B 9.89
Embecta (EMBC) United States $0.627B 4.22
InnovAge Holding (INNV) United States $0.567B 0.00
SBC Medicals (SBC) United States $0.552B 0.00
LifeMD (LFMD) United States $0.544B 0.00
Sonida Senior Living (SNDA) United States $0.486B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
Omada Health (OMDA) $0.461B 0.00
So-Young (SY) China $0.389B 0.00
Enhabit (EHAB) United States $0.375B 30.88
COMPASS Pathways (CMPS) United Kingdom $0.348B 0.00
Performant Healthcare (PHLT) United States $0.338B 0.00
Beauty Health (SKIN) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.256B 0.00
DocGo (DCGO) United States $0.153B 25.00
Pheton Holdings (PTHL) China $0.134B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
KindlyMD (NAKA) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.055B 0.00
ModivCare (MODV) United States $0.054B 0.00
Biodesix (BDSX) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00